language_icon
EN
HI

Epigral Share price

EPIGRAL

1215.65

21.10 (1.77%)
NSE
BSE
Last updated on 30 Apr, 2026 | 15:56 IST
Today's High

1229.00

Today's Low

1182.00

52 Week Low

807.00

52 Week High

2114.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Epigral Chart

Epigral Share Key Metrics

Volume
57448.00
Market Cap
5244.48 CR
LTQ@LTP
2@1215.65
ATP
1211.75
Var Margin
21.52 %
Circuit Range
955.65-1433.45
Delivery %
45.29 %
Value
6.96 CR
ASM/GSM
No
Market Lot
1

Summary

Epigral share price stands at ₹1215.65 at 30 Apr, 2026 | 15:56. The stock Epigral intraday movement has stayed between ₹1182.00 and ₹1229.00, while on a 52-week basis it has fluctuated from ₹807.00 to ₹2114.00.
In terms of trading activity, Epigral has recorded a volume of 57448 shares. The Epigral has a market cap of ₹43141338. The stock’s Average Traded Price (ATP) stands at ₹121175, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2, 121565.
The Epigral operates within a circuit range of ₹955.65-1433.45 – ₹955.65-1433.45, with a Value of ₹6.96 CR. The Delivery Percentage for the day is 45.29%. Additionally, Epigral currently falls under the No framework, and trades with a market lot size of 1.

Epigral Fundamentals

View More
P/E Ratio

15.28

P/B Ratio

2.41

Div. Yield

0.5

Sector P/E

41.74

Sector P/B

2.55

Sec. Div. Yield

0.46

Epigral Resistance and Support

Pivot 1206.05

Resistance

First Resistance

1222.1

Second Resistance

1249.65

Third Resistance

1265.7

Support

First Support

1178.5

Second Support

1162.45

Third Support

1134.9

Epigral Shareholding Pattern

View More
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

68.83%

Mutual Fund

4.9%

Insurance

0%

Foreign Institutional Investors

1.54%

Domestic Institutional Investors

0.02%

Retail

24.7%

Others

0.01%

Total Promoters
MAR '26
68.83%

Epigral Corporate Actions

DateAgenda
2026-05-02Audited Results & Final Dividend
2026-01-30Quarterly Results
2025-11-10Quarterly Results
2025-08-02Quarterly Results & Fund Raising
2025-05-05Audited Results & Final Dividend
2025-01-27Quarterly Results & Interim Dividend

Epigral News

Epigral Limited

Epigral's board will meet on May 2, 2026, to consider audited standalone and cons. financial results for FY26. They will also consider a final dividend for shareholders.
Apr 27 2026 12:04:00

Epigral Limited

Epigral Limited's board will convene on May 2, 2026, to consider and approve the audited financial results for the fourth quarter and full financial year ending March 31, 2026. The agenda also includes a potential recommendation for a final dividend.
Apr 27 2026 12:04:00

Epigral Limited

Epigral Limited initiated a postal ballot for the re-appointment of three Non-Executive Independent Directors. Mr. Sanjay Asher, Mr. Kanubhai Patel, and Mr. Raju Swamy are proposed for a second five-year term each, effective May 20, 2026, with voting ending May 19, 2026.
Apr 17 2026 12:04:00

Epigral Limited

Epigral is seeking shareholder approval through postal ballot for the re-appointment of three Non-Executive Independent Directors for a second five-year term. The e-voting period is scheduled from April 20, 2026, to May 19, 2026, with results by May 21, 2026.
Apr 17 2026 12:04:00

Epigral Limited

Epigral Limited reappointed Mr. Sanjay Asher, Mr. Kanubhai Patel, and Mr. Raju Swamy as Non-Executive Independent Directors for a second 5-year term. These appointments, effective May 20, 2026, are subject to shareholder approval via Postal Ballot.
Apr 16 2026 17:04:00

Epigral Ltd - 543332 - Re-Appointment Of Non-Executive Independent Directors For Second Term

Epigral Limited's Board re-appointed three Non-Executive Independent Directors, Mr. Sanjay Asher, Mr. Kanubhai Patel, and Mr. Raju Swamy. Each re-appointment is for a second term of five consecutive years, commencing May 20, 2026, subject to shareholder approval via Postal Ballot.
Apr 16 2026 17:04:00

Epigral Limited

Epigral Limited will host an investor and analyst meet on April 13, 2026. The meeting, organized by Sunidhi Securities & Finance Ltd. via video conferencing, will not involve the sharing of any unpublished price sensitive information.
Apr 09 2026 14:04:00

Epigral Limited

Epigral Limited will hold an investor/analyst meeting with Dhamma Capital on April 10, 2026, via video conferencing. No unpublished price sensitive information will be shared during the meeting.
Apr 09 2026 14:04:00

Epigral Limited

Epigral Limited will conduct a non-deal roadshow with institutional investors on April 8, 2026, in Mumbai. The one-on-one meetings are organized by Sunidhi Securities, and no unpublished price sensitive information will be shared.
Apr 04 2026 12:04:00

Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Epigral Limited to conduct a non-deal roadshow with institutional investors on April 8, 2026, in Mumbai. The one-on-one meetings, organized by Sunidhi Securities, will not involve sharing unpublished price sensitive information.
Apr 04 2026 11:04:00
Read More

About Epigral

NSE : 5382  
BSE : 543332  
ISIN : INE071N01016  

Epigral Management

NamePosition
Gaurang TrivediCompany Secretary & Compliance Officer
Maulik PatelChairman & Managing Director
View More

Epigral FAQs

The Buying Price of Epigral share is 1215.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Epigral stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Epigral, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Epigral shares is 15.28. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Epigral shares is 2.41. Useful to assess the stock's value relative to its book value.

To assess Epigral’s valuation compare Sector P/E, P/B which are 41.74 & 2.55 with sector averages, along with growth rates and financial metrics.

The Market Cap of Epigral is 5244.48 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Epigral share price is 2114.00 & 807.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Epigral belongs to the Chemicals sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost